Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tara McCready

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Therapeutic Drug Monitoring|January 25, 2005
The portal immunosuppressive storm: relevance to islet transplantation?A M James Shapiro, Heather L Gallant, Er Geng Hao, et al.
Plos One|April 25, 2015
Patients' knowledge, attitudes, behaviour and health care experiences on the prevention, detection, management and control of hypertension in Colombia: a qualitative studyHelena Legido-Quigley, Paul Anthony Camacho Lopez, Dina Balabanova, et al.
BMC Medicine|June 20, 2022
Length of initial prescription at hospital discharge and long-term medication adherence for elderly, post-myocardial infarction patients: a population-based interrupted time series studyJ D Schwalm, Noah M Ivers, Zachary Bouck, et al.
European Heart Journal|November 30, 2013
Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges, Salim Yusuf, Amir Attaran, et al.
Lancet (London, England)|September 7, 2019
A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trialJon-David Schwalm, Tara McCready, Patricio Lopez-Jaramillo, et al.
BMC Health Services Research|July 3, 2015
Understanding the modifiable health systems barriers to hypertension management in Malaysia: a multi-method health systems appraisal approachIsabelle Risso-Gill, Dina Balabanova, Fadhlina Majid, et al.
American Heart Journal|July 18, 2018
Rationale and design of a cluster randomized trial of a multifaceted intervention in people with hypertension: The Heart Outcomes Prevention and Evaluation 4 (HOPE-4) StudyJon-David Reid Schwalm, Tara McCready, Pablo Lamelas, et al.
The Lancet. Global Health|January 13, 2024
Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive Heart Failure (G-CHF) registryMarjan Walli-Attaei, Philip Joseph, Isabelle Johansson, et al.
Global Heart|January 15, 2018
Development, Testing, and Implementation of a Training Curriculum for Nonphysician Health Workers to Reduce Cardiovascular DiseaseMaheer Khan, Pablo Lamelas, Hadi Musa, et al.
American Heart Journal|July 18, 2020
A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registryPhilip Joseph, Hisham Dokainish, Tara McCready, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Therapeutic Drug Monitoring|January 25, 2005
The portal immunosuppressive storm: relevance to islet transplantation?A M James Shapiro, Heather L Gallant, Er Geng Hao, et al.
Plos One|April 25, 2015
Patients' knowledge, attitudes, behaviour and health care experiences on the prevention, detection, management and control of hypertension in Colombia: a qualitative studyHelena Legido-Quigley, Paul Anthony Camacho Lopez, Dina Balabanova, et al.
BMC Medicine|June 20, 2022
Length of initial prescription at hospital discharge and long-term medication adherence for elderly, post-myocardial infarction patients: a population-based interrupted time series studyJ D Schwalm, Noah M Ivers, Zachary Bouck, et al.
European Heart Journal|November 30, 2013
Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges, Salim Yusuf, Amir Attaran, et al.
Lancet (London, England)|September 7, 2019
A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trialJon-David Schwalm, Tara McCready, Patricio Lopez-Jaramillo, et al.
BMC Health Services Research|July 3, 2015
Understanding the modifiable health systems barriers to hypertension management in Malaysia: a multi-method health systems appraisal approachIsabelle Risso-Gill, Dina Balabanova, Fadhlina Majid, et al.
American Heart Journal|July 18, 2018
Rationale and design of a cluster randomized trial of a multifaceted intervention in people with hypertension: The Heart Outcomes Prevention and Evaluation 4 (HOPE-4) StudyJon-David Reid Schwalm, Tara McCready, Pablo Lamelas, et al.
The Lancet. Global Health|January 13, 2024
Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive Heart Failure (G-CHF) registryMarjan Walli-Attaei, Philip Joseph, Isabelle Johansson, et al.
Global Heart|January 15, 2018
Development, Testing, and Implementation of a Training Curriculum for Nonphysician Health Workers to Reduce Cardiovascular DiseaseMaheer Khan, Pablo Lamelas, Hadi Musa, et al.
American Heart Journal|July 18, 2020
A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registryPhilip Joseph, Hisham Dokainish, Tara McCready, et al.
Pageof 4